Topical PUFA-Resorcinol Composition for Synergistic Inflammation Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing personal care compositions fail to effectively deliver synergistic anti-inflammatory benefits, and many anti-inflammatory actives are not derived from natural sources.
Innovation Solution
A personal care composition comprising polyunsaturated fatty acids (PUFAs) such as DHA, EPA, and DGLA, combined with 4-substituted resorcinol compounds, in a specific mole ratio, derived from natural sources, to provide synergistic anti-inflammatory effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing personal care compositions use conventional anti-inflammatory actives, then inflammation can be treated, but synergistic anti-inflammatory benefits are not achieved
Solution Approach 1:
The patent combines polyunsaturated fatty acids (PUFAs) with 4-substituted resorcinol compounds in a specific composition to achieve synergistic anti-inflammatory effects. This merging of two different active ingredients creates a combination that provides greater anti-inflammatory benefit than either ingredient alone, directly resolving the contradiction between achieving reliable anti-inflammatory treatment and obtaining synergistic benefits.
Solution Approach 2:
The invention creates a composite personal care composition containing both PUFAs and 4-substituted resorcinol compounds. This composite formulation leverages the complementary properties of both ingredient classes to deliver enhanced anti-inflammatory activity, transforming conventional single-ingredient approaches into a multi-component system that achieves synergistic effects.
2Reliability
If anti-inflammatory actives are used from non-natural sources, then inflammation can be treated, but actives derived from natural sources are not utilized
Solution Approach 1:
The patent specifies that the 4-substituted resorcinol compound should be derived from natural sources such as plant extracts, representing a parameter change from synthetic to natural origin. This maintains effective anti-inflammatory treatment while incorporating naturally-derived actives, resolving the contradiction between treatment reliability and natural source utilization.
3Ease of manufacture
If PUFAs and 4-substituted resorcinol compounds are combined in incorrect ratios, then composition can be formulated, but synergistic anti-inflammatory activity is not achieved
Solution Approach 1:
The patent defines a specific mole ratio range (1:5 to 5:1) for PUFAs to 4-substituted resorcinol compounds to achieve synergistic effects. By optimizing this critical parameter, the invention ensures that the composition formulation process leads to reliable synergistic anti-inflammatory activity, resolving the contradiction between ease of formulation and achievement of synergistic activity.
Data Source
AI summary
The invention relates to a personal care composition, more particularly to a composition for application to a topical surface that prevents or reduces inflammation. The composition could be delivered in the form of a skin, scalp, hair or oral care product, more particularly a skin care product. The benefit is delivered via a combination of a polyunsaturated fatty acid (PUFA) or ester thereof selected from docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), DHA-ethyl ester, EPA- ethyl ester, DHA-triglyceride, EPA-triglyceride, dihomogamma-Linolenic Acid (DGLA), DGLA-ethyl ester, DGLA-triglyceride or combinations thereof and a 4-substituted resorcinol compound, wherein the mole ratio of the PUFA or ester thereof to the 4- substituted resorcinol compound is 5:1 to 1:5.